PIK3C2A and myopathy: In a clinical setting, myopathy is generally diagnosed according to an elevated circulating level of creatine phosphokinase (CPK) that is released from disrupted myocytes, but this enzyme is unstable such that its circulating level in blood can be apparently lost before blood sampling.